awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q24632064-A9F70CE6-A22A-48C5-AE76-7C4284D3C224
Q24632064-A9F70CE6-A22A-48C5-AE76-7C4284D3C224
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24632064-A9F70CE6-A22A-48C5-AE76-7C4284D3C224
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
P2860
Q24632064-A9F70CE6-A22A-48C5-AE76-7C4284D3C224
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24632064-A9F70CE6-A22A-48C5-AE76-7C4284D3C224
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70ae0718ce07ef5b847145cc0fa4be795e369769
P2860
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.